All articles by Johney
Johney
Medtronic to acquire medical technology company Affera for $925m
The deal will bolster Medtronic’s spectrum of advanced cardiac ablation products and accessories.
Johnson & Johnson to expand digital surgery ecosystem with Microsoft
JJMDC and Microsoft will work to improve patient outcomes with AI, machine learning and data insights.
Kantaro and Atrys Health partner for distribution of Covid-19 tests
Kantaro Biosciences and its manufacturing partner Bio-Techne have signed a marketing and distribution agreement with biomedical company Atrys Health for Covid-19 tests.
FDA grants marketing approval for sleep apnea reduction device
The US Food and Drug Administration (FDA) has granted marketing authorisation of eXciteOSA device to Signifier Medical Technologies.
Oxford Immunotec updates configuration of SARS-CoV-2 Kit
British diagnostic company Oxford Immunotec has updated the configuration of its T-SPOT Discovery SARS-CoV-2 kit.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Quidel launches new manufacturing unit to mass produce Covid-19 tests
US-based diagnostic testing solutions provider Quidel has opened a new manufacturing facility for the mass manufacture of the company’s QuickVue SARS rapid antigen tests for Covid-19.
Omega Laboratories introduces Covid-19 PCR testing services
Omega Laboratories has launched a new suite of Covid-19 laboratory testing services, which include polymerase chain reaction (RT-PCR) testing for SARS-COV-2.
Takeda sells TachoSil surgical patch to Corza Health for $422.4m
Takeda has completed the previously announced sale of TachoSil Fibrin Sealant Patch to Corza Health for €350m ($422.4m) in cash.
Roche obtains CE Mark for SARS-CoV-2 Rapid Antigen Test Nasal
Swiss healthcare company Roche has secured the CE Mark for its new SARS-CoV-2 Rapid Antigen Test Nasal, a test kit for Covid-19.
FDA approves Medtronic’s DTA system to treat patients with atrial fibrillation
Medtronic has secured approval for its DiamondTemp Ablation (DTA) system from the US Food and Drug Administration (FDA) for treating patients with atrial fibrillation (AF).